ArticleMolecular therapy : the journal of the American Society of Gene Therapy2008

In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

Gerhard Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.